A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction

IgA nephropathy frequently leads to progressive CKD. Although interest surrounds use of immunosuppressive agents added to standard therapy, several recent studies have questioned efficacy of these agents. Depleting antibody–producing B cells potentially offers a new therapy. In this open label, mult...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Am Soc Nephrol
Main Authors: Lafayette, Richard A., Canetta, Pietro A., Rovin, Brad H., Appel, Gerald B., Novak, Jan, Nath, Karl A., Sethi, Sanjeev, Tumlin, James A., Mehta, Kshama, Hogan, Marie, Erickson, Stephen, Julian, Bruce A., Leung, Nelson, Enders, Felicity T., Brown, Rhubell, Knoppova, Barbora, Hall, Stacy, Fervenza, Fernando C.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Nephrology 2017
Teme:
Clinical Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5373458/
https://ncbi.nlm.nih.gov/pubmed/27821627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2016060640
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki